EP3500564
Díasýlglýseról-asýltransferasa 2 hindrar
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
9.8.2017EP published:
7.10.2020EP application number:
17761332.0
EP translation filed:
10.11.2020Grant published:
15.12.2020EPO information:
European Patent Register
Max expiry date:
8.8.2037Expiry date:
8.8.2026Next due date:
31.8.2026
Title:
DIACYLGLYCEROL ACYLTRANSFERASE 2 INHIBITORS
Timeline
Today
9.8.2017EP application
7.10.2020EP Publication
10.11.2020Translation submitted
15.12.2020Registration published
8.8.2026Expires
Owner
Name:
Pfizer Inc.Address:
66 Hudson Boulevard East, New York, NY 10001-2192, US
Inventor
Name:
BOEHM, MarkusAddress:
Mansfield MA 02048, US
Name:
CABRAL, ShawnAddress:
Groton CT 06340, US
Name:
DOWLING, Matthew S.Address:
Old Lyme CT 06371, US
Name:
FUTATSUGI, KentaroAddress:
Sharon MA 02067, US
Name:
HUARD, KimAddress:
Medford MA 02155, US
Name:
LEE, Esther Cheng YinAddress:
Somerville MA 02144, US
Name:
LI, QifangAddress:
Stonington CT 06378, US
Name:
LONDREGAN, Allyn T.Address:
Barrington RI 02806, US
Name:
POLIVKOVA, JanaAddress:
Mystic CT 06355, US
Name:
PRICE, David A.Address:
Concord MA 01742, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201662377137 PDate:
19.8.2016Country:
US
Classification
Categories:
C07D 401/14, A61K 31/506, A61P 3/00
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 31.5.2021
Expires: 8.8.2022
Payer: Árnason Faktor ehf.
Number: 6
Paid: 12.7.2022
Expires: 8.8.2023
Payer: Árnason Faktor ehf.
Number: 7
Paid: 21.6.2023
Expires: 8.8.2024
Payer: Árnason Faktor ehf.
Number: 8
Paid: 23.7.2024
Expires: 8.8.2025
Payer: Árnason Faktor ehf.
Number: 9
Paid: 29.12.2025
Expires: 8.8.2026
Payer: Árnason Faktor ehf.